GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ultimovacs ASA (STU:7UM) » Definitions » Net Interest Income (for Banks)

Ultimovacs ASA (STU:7UM) Net Interest Income (for Banks)


View and export this data going back to 2021. Start your Free Trial

What is Ultimovacs ASA Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


Ultimovacs ASA (STU:7UM) Business Description

Industry
Traded in Other Exchanges
Address
Ullernchausseen 64, Oslo, NOR, 0379
Ultimovacs ASA is a pharmaceutical company involved in developing novel immunotherapies against cancer. Its product candidate is UV1, a peptide-based vaccine inducing T cell responses against the universal cancer antigen telomerase. The company and its proprietary technology are based on preclinical and clinical research on immunotherapies conducted at the Oslo University Hospital.